Erratum: Atrial Fibrillation and the Risk ofMyocardial Infarction (JAMA Internal Medicine (2014) 174:1 Doi:10.1001/jamainternmed.2013.11912);Atrial fibrillation and the risk of myocardial infarction

JAMA Internal Medicine

Volumn 174, Issue 1, 2014, Pages 308-

  Soliman, Elsayed Z ^a   Safford, Monika M ^b   Muntner, Paul ^c   Khodneva, Yulia ^b   Dawood, Farah Z ^a   Zakai, Neil A ^d   Thacker, Evan L ^c   Judd, Suzanne ^c   Howard, Virginia J ^c   Howard, George ^e   Herrington, David M ^a   Cushman, Mary ^d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; STATIN (PROTEIN); WARFARIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

AFRICAN AMERICANS; AGED; ATRIAL FIBRILLATION; COHORT STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 84892426726     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.11912     Document Type: Erratum

References (52)

1. Go AS, Hylek EM, Phillips K.A., et al Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-2375.
2. Miyasaka Y, Barnes ME, Gersh B.J., et al Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119-125.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946-952.
4. Miyasaka Y, Barnes ME, Bailey K.R., et al Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49(9):986-992.
5. Conen D, Chae CU, Glynn R.J., et al Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011;305(20):2080-2087.
6. Kannel WB, Benjamin EJ Status of the epidemiology of atrial fibrillation. Med Clin North Am. 2008;92(1):17-40.
7. Benjamin EJ, Chen PS, Bild D.E., et al Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009;119(4):606-618.
8. Schmitt J, Duray G, Gersh B.J., Hohnloser SH Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038-1045.
9. Garg RK, Jolly N. Acute myocardial infarction secondary to thromboembolism in a patient with atrial fibrillation. Int J Cardiol. 2007;123(1):e18-e20.
10. Van de Walle S, Dujardin K. A case of coronary embolism in a patient with paroxysmal atrial fibrillation receiving tamoxifen. Int J Cardiol. 2007;123(1):66-68.
11. Sakai K, Inoue K, Nobuyoshi M. Aspiration thrombectomy of a massive thrombotic embolus in acute myocardial infarction caused by coronary embolism. Int Heart J. 2007;48(3):387-392.
12. Kleczyński P., Dziewierz A, Rakowski T., et al Cardioembolic acute myocardial infarction and stroke in a patient with persistent atrial fibrillation. Int J Cardiol. 2012;161(3):e46-e47.
13. Hernández F., Pombo M, Dalmau R., et al Acute coronary embolism: angiographic diagnosis and treatment with primary angioplasty. Catheter Cardiovasc Interv. 2002;55(4):491-494.
14. Iwama T, Asami K, Kubo I., Kitazume H. Hypertrophic cardiomyopathy complicated with acute myocardial infarction due to coronary embolism. Intern Med. 1997;36(9):613-617.
15. Takenaka T, Horimoto M, Igarashi K., Yoshie H, Tsujino I, Morihira M. Multiple coronary thromboemboli complicating valvular heart disease and atrial fibrillation. Am Heart J. 1996;131(1): 194-196.
16. Camaro C, Aengevaeren WR Acute myocardial infarction due to coronary artery embolism in a patient with atrial fibrillation. Neth Heart J. 2009;17(7-8):297-299.
17. Howard VJ, Cushman M, Pulley L., et al The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25(3):135-143.
18. Safford MM, Brown TM, Muntner P.M., et al.; REGARDS Investigators. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308(17):1768-1774.
19. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, MA: Wright-OSG; 1982.
20. Soliman EZ, Howard G, Meschia J.F., et al Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2011;42(10):2950-2953.
21. Pullicino PM, McClure LA, Wadley V.G., et al Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke. 2009;40(12): 3706-3710.
22. Gage BF, Waterman AD, Shannon W, Boechler M., Rich MW, Radford MJ Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864-2870.
23. Levey AS, Stevens LA, Schmid C.H., et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
24. Meschia JF, Merrill P, Soliman E.Z., et al Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2010;41(4):581-587.
25. Rothberg MB, Celestin C, Fiore L.D., Lawler E., Cook JR Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med. 2005;143(4):241-250.
26. Lip GY, Lane DA Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? Am J Med. 2010;123(9): 785-789.
27. Watanabe H, Watanabe T, Sasaki S., Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009;158(4):629-636.
28. Bansal N, Fan D, Hsu C.Y., Ordonez JD, Marcus GM, Go AS Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013;127(5):569-574.
29. Wang TJ, Larson MG, Levy D, et al Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920-2925.
30. Aviles RJ, Martin DO, Apperson-Hansen C, et al Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006-3010.
31. Ridker PM, Rifai N, Stampfer M.J., Hennekens CH Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101(15):1767-1772.
32. Ridker PM, Hennekens CH, Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12): 836-843.
33. Rienstra M, Sun JX, Magnani J.W., et al White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012;109(4):533-537.
34. Issac TT, Dokainish H, Lakkis NM Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021-2028.
35. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22):2263-2270.
36. Lim HS, Willoughby SR, Schultz C, et al Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013;61(8):852-860.
37. Mondillo S, Sabatini L, Agricola E., et al Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. Int J Cardiol. 2000;75(2-3):227-232.
38. Lip GY, Lowe GD, Rumley A, Dunn FG Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J. 1995;73(6):527-533.
39. Willoughby SR, Roberts-Thomson RL, Lim H.S., et al Atrial platelet reactivity in patients with atrial fibrillation. Heart Rhythm. 2010;7(9):1178-1183.
40. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation. 2002;105(18):2130-2132.
41. Akar JG, Jeske W, Wilber DJ Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol. 2008;51(18):1790-1793.
42. Watson T, Shantsila E, Lip GY Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009;373(9658):155-166.
43. Frustaci A, Chimenti C, Bellocci F., Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180-1184.
44. Fukuchi M, Watanabe J, Kumagai K., et al Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol. 2001;37(5):1436-1442.
45. Matsue Y, Suzuki M, Abe M., et al Endothelial dysfunction in paroxysmal atrial fibrillation as a prothrombotic state: comparison with permanent/persistent atrial fibrillation. J Atheroscler Thromb. 2011;18(4):298-304.
46. Wong CX, Lim HS, Schultz C.D., Sanders P., Worthley MI, Willoughby SR Assessment of endothelial function in atrial fibrillation: utility of peripheral arterial tonometry. Clin Exp Pharmacol Physiol. 2012;39(2):141-144.
47. Minamino T, Kitakaze M, Sato H., et al Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol. 1997;17(11):3191-3195.
48. Skalidis EI, Zacharis EA, Tsetis D.K., et al Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol. 2007;99(9):1258-1262.
49. Prizel KR, Hutchins GM, Bulkley BH Coronary artery embolism and myocardial infarction. Ann Intern Med. 1978;88(2):155-161.
50. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525-2538.
51. Saaby L, Poulsen TS, Hosbond S, et al Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126(9):789-797.
52. Fonseca C, Oliveira AG, Mota T, et al.; EPICA Investigators. Evaluation of the performance and concordance of clinical questionnaires for the diagnosis of heart failure in primary care. Eur J Heart Fail. 2004;6(6):813-822. Stroke